APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologic Therapeutic Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biologic Therapeutic Drug Industry Growth and Trends Forecast to 2032

31 December 2025101 pages

Choose your research edition.

Industry ResearchBiologic Therapeutic Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologic Therapeutic Drug Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biologic Therapeutic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologic Therapeutic Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologic Therapeutic Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

According to APO Research, the global Biologic Therapeutic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biologic Therapeutic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biologic Therapeutic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologic Therapeutic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Biologic Therapeutic Drug market include Merck and Co. Inc., Pfizer Inc., AstraZeneca, Smith Medical, Retractable Technologies, Inc., Novartis Global, H. Lundbeck A/S, GlaxoSmithKline Plc. and Concord Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biologic Therapeutic Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biologic Therapeutic Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biologic Therapeutic Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biologic Therapeutic Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Biologic Therapeutic Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biologic Therapeutic Drug Market by Company

Merck and Co. Inc.

Pfizer Inc.

AstraZeneca

Smith Medical

Retractable Technologies, Inc.

Novartis Global

H. Lundbeck A/S

GlaxoSmithKline Plc.

Concord Biotech

Aurobindo Pharma Ltd.

Biologic Therapeutic Drug Segment by Type

Monoclonal Antibodies

Vaccines

Therapeutic Proteins

Biologic Therapeutic Drug Segment by Application

Clinical Medicine

Laboratory

Others

Biologic Therapeutic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Therapeutic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologic Therapeutic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Therapeutic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Biologic Therapeutic Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Biologic Therapeutic Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Biologic Therapeutic Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Biologic Therapeutic Drug Market Share by Region (2021-2026) Table 4. Global Biologic Therapeutic Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Biologic Therapeutic Drug Market Share by Region (2027-2032) Table 6. Global Biologic Therapeutic Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biologic Therapeutic Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Biologic Therapeutic Drug Market Size Share by Type (2021-2026) Table 9. Global Biologic Therapeutic Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Biologic Therapeutic Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Biologic Therapeutic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Biologic Therapeutic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Biologic Therapeutic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Biologic Therapeutic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Biologic Therapeutic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Biologic Therapeutic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Biologic Therapeutic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Biologic Therapeutic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Biologic Therapeutic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Biologic Therapeutic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Biologic Therapeutic Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Biologic Therapeutic Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Biologic Therapeutic Drug Market Size Share by Application (2021-2026) Table 24. Global Biologic Therapeutic Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Biologic Therapeutic Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Biologic Therapeutic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Biologic Therapeutic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Biologic Therapeutic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Biologic Therapeutic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Biologic Therapeutic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Biologic Therapeutic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Biologic Therapeutic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Biologic Therapeutic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Biologic Therapeutic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Biologic Therapeutic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Biologic Therapeutic Drug Industry Trends Table 37. Biologic Therapeutic Drug Industry Drivers Table 38. Biologic Therapeutic Drug Industry Opportunities and Challenges Table 39. Biologic Therapeutic Drug Industry Restraints Table 40. Global Biologic Therapeutic Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Biologic Therapeutic Drug Revenue Market Share by Company (2021-2026) Table 42. Global Biologic Therapeutic Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Biologic Therapeutic Drug Key Company Headquarters & Area Served Table 44. Global Biologic Therapeutic Drug Company, Product Type & Application Table 45. Global Biologic Therapeutic Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Biologic Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Merck and Co. Inc. Company Information Table 49. Merck and Co. Inc. Business Overview Table 50. Merck and Co. Inc. Biologic Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Merck and Co. Inc. Biologic Therapeutic Drug Product Portfolio Table 52. Merck and Co. Inc. Recent Development Table 53. Pfizer Inc. Company Information Table 54. Pfizer Inc. Business Overview Table 55. Pfizer Inc. Biologic Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Pfizer Inc. Biologic Therapeutic Drug Product Portfolio Table 57. Pfizer Inc. Recent Development Table 58. AstraZeneca Company Information Table 59. AstraZeneca Business Overview Table 60. AstraZeneca Biologic Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. AstraZeneca Biologic Therapeutic Drug Product Portfolio Table 62. AstraZeneca Recent Development Table 63. Smith Medical Company Information Table 64. Smith Medical Business Overview Table 65. Smith Medical Biologic Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Smith Medical Biologic Therapeutic Drug Product Portfolio Table 67. Smith Medical Recent Development Table 68. Retractable Technologies, Inc. Company Information Table 69. Retractable Technologies, Inc. Business Overview Table 70. Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Retractable Technologies, Inc. Biologic Therapeutic Drug Product Portfolio Table 72. Retractable Technologies, Inc. Recent Development Table 73. Novartis Global Company Information Table 74. Novartis Global Business Overview Table 75. Novartis Global Biologic Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Novartis Global Biologic Therapeutic Drug Product Portfolio Table 77. Novartis Global Recent Development Table 78. H. Lundbeck A/S Company Information Table 79. H. Lundbeck A/S Business Overview Table 80. H. Lundbeck A/S Biologic Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. H. Lundbeck A/S Biologic Therapeutic Drug Product Portfolio Table 82. H. Lundbeck A/S Recent Development Table 83. GlaxoSmithKline Plc. Company Information Table 84. GlaxoSmithKline Plc. Business Overview Table 85. GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline Plc. Biologic Therapeutic Drug Product Portfolio Table 87. GlaxoSmithKline Plc. Recent Development Table 88. Concord Biotech Company Information Table 89. Concord Biotech Business Overview Table 90. Concord Biotech Biologic Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Concord Biotech Biologic Therapeutic Drug Product Portfolio Table 92. Concord Biotech Recent Development Table 93. Aurobindo Pharma Ltd. Company Information Table 94. Aurobindo Pharma Ltd. Business Overview Table 95. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product Portfolio Table 97. Aurobindo Pharma Ltd. Recent Development Table 98. North America Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Biologic Therapeutic Drug Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Biologic Therapeutic Drug Market Share by Country (2021-2026) Table 101. North America Biologic Therapeutic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Biologic Therapeutic Drug Market Share Forecast by Country (2027-2032) Table 103. Europe Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Biologic Therapeutic Drug Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Biologic Therapeutic Drug Market Share by Country (2021-2026) Table 106. Europe Biologic Therapeutic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Biologic Therapeutic Drug Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Biologic Therapeutic Drug Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Biologic Therapeutic Drug Market Share by Country (2021-2026) Table 111. Asia-Pacific Biologic Therapeutic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Biologic Therapeutic Drug Market Share Forecast by Country (2027-2032) Table 113. Latin America Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Biologic Therapeutic Drug Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Biologic Therapeutic Drug Market Share by Country (2021-2026) Table 116. Latin America Biologic Therapeutic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Biologic Therapeutic Drug Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Biologic Therapeutic Drug Market Share by Country (2021-2026) Table 121. Middle East & Africa Biologic Therapeutic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Biologic Therapeutic Drug Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Biologic Therapeutic Drug Product Image Figure 3. Global Biologic Therapeutic Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Biologic Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Biologic Therapeutic Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Biologic Therapeutic Drug Market Share by Region (2021-2032) Figure 7. North America Biologic Therapeutic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Biologic Therapeutic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Biologic Therapeutic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Biologic Therapeutic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Biologic Therapeutic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Monoclonal Antibodies Image Figure 13. Global Monoclonal Antibodies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Vaccines Image Figure 15. Global Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Therapeutic Proteins Image Figure 17. Global Therapeutic Proteins Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Biologic Therapeutic Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Biologic Therapeutic Drug Market Share by Type 2025 VS 2032 Figure 20. North America Biologic Therapeutic Drug Market Size Share by Type (2021-2032) Figure 21. Europe Biologic Therapeutic Drug Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Biologic Therapeutic Drug Market Size Share by Type (2021-2032) Figure 23. Latin America Biologic Therapeutic Drug Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Biologic Therapeutic Drug Market Size Share by Type (2021-2032) Figure 25. Clinical Medicine Image Figure 26. Global Clinical Medicine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Laboratory Image Figure 28. Global Laboratory Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Biologic Therapeutic Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Biologic Therapeutic Drug Market Share by Application 2025 VS 2032 Figure 33. North America Biologic Therapeutic Drug Market Size Share by Application (2021-2032) Figure 34. Europe Biologic Therapeutic Drug Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Biologic Therapeutic Drug Market Size Share by Application (2021-2032) Figure 36. Latin America Biologic Therapeutic Drug Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Biologic Therapeutic Drug Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Biologic Therapeutic Drug Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Biologic Therapeutic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Biologic Therapeutic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Biologic Therapeutic Drug Market Share by Country (2021-2032) Figure 43. Europe Biologic Therapeutic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Biologic Therapeutic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Biologic Therapeutic Drug Market Share by Country (2021-2032) Figure 46. Asia-Pacific Biologic Therapeutic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Biologic Therapeutic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Biologic Therapeutic Drug Market Share by Country (2021-2032) Figure 49. Latin America Biologic Therapeutic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Biologic Therapeutic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Biologic Therapeutic Drug Market Share by Country (2021-2032) Figure 52. Middle East & Africa Biologic Therapeutic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Biologic Therapeutic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Biologic Therapeutic Drug Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Vaccines
  • Therapeutic Proteins
Applications
  • Clinical Medicine
  • Laboratory
  • Others
Companies covered
  • Merck and Co. Inc.
  • Pfizer Inc.
  • AstraZeneca
  • Smith Medical
  • Retractable Technologies, Inc.
  • Novartis Global
  • H. Lundbeck A/S
  • GlaxoSmithKline Plc.
  • Concord Biotech
  • Aurobindo Pharma Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Biologic Therapeutic Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Biologic Therapeutic Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Biologic Therapeutic Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Biologic Therapeutic Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Biologic Therapeutic Drug Market Size (2021-2032)
  8. 1.5.1 North America Biologic Therapeutic Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Biologic Therapeutic Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Biologic Therapeutic Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Biologic Therapeutic Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Biologic Therapeutic Drug Market Size Growth Rate (2021-2032)
2 Biologic Therapeutic Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Monoclonal Antibodies
  3. 2.1.2 Vaccines
  4. 2.1.3 Therapeutic Proteins
  5. 2.2 Global Biologic Therapeutic Drug Market Size by Type
  6. 2.2.1 Global Biologic Therapeutic Drug Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Biologic Therapeutic Drug Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Biologic Therapeutic Drug Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Biologic Therapeutic Drug Market Size by Regions
  10. 2.3.1 North America Biologic Therapeutic Drug Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Biologic Therapeutic Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Biologic Therapeutic Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Biologic Therapeutic Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Biologic Therapeutic Drug Market Size Breakdown by Type (2021-2026)
3 Biologic Therapeutic Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Clinical Medicine
  3. 3.1.2 Laboratory
  4. 3.1.3 Others
  5. 3.2 Global Biologic Therapeutic Drug Market Size by Application
  6. 3.2.1 Global Biologic Therapeutic Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Biologic Therapeutic Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Biologic Therapeutic Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Biologic Therapeutic Drug Market Size by Regions
  10. 3.3.1 North America Biologic Therapeutic Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Biologic Therapeutic Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Biologic Therapeutic Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Biologic Therapeutic Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Biologic Therapeutic Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Biologic Therapeutic Drug Industry Trends
  2. 4.2 Biologic Therapeutic Drug Industry Drivers
  3. 4.3 Biologic Therapeutic Drug Industry Opportunities and Challenges
  4. 4.4 Biologic Therapeutic Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Biologic Therapeutic Drug Revenue (2021-2026)
  2. 5.2 Global Biologic Therapeutic Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Biologic Therapeutic Drug Key Company Headquarters & Area Served
  4. 5.4 Global Biologic Therapeutic Drug Company, Product Type & Application
  5. 5.5 Global Biologic Therapeutic Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Biologic Therapeutic Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Biologic Therapeutic Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Biologic Therapeutic Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Merck and Co. Inc.
  2. 6.1.1 Merck and Co. Inc. Company Information
  3. 6.1.2 Merck and Co. Inc. Business Overview
  4. 6.1.3 Merck and Co. Inc. Biologic Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Merck and Co. Inc. Biologic Therapeutic Drug Product Portfolio
  6. 6.1.5 Merck and Co. Inc. Recent Developments
  7. 6.2 Pfizer Inc.
  8. 6.2.1 Pfizer Inc. Company Information
  9. 6.2.2 Pfizer Inc. Business Overview
  10. 6.2.3 Pfizer Inc. Biologic Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Inc. Biologic Therapeutic Drug Product Portfolio
  12. 6.2.5 Pfizer Inc. Recent Developments
  13. 6.3 AstraZeneca
  14. 6.3.1 AstraZeneca Company Information
  15. 6.3.2 AstraZeneca Business Overview
  16. 6.3.3 AstraZeneca Biologic Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 AstraZeneca Biologic Therapeutic Drug Product Portfolio
  18. 6.3.5 AstraZeneca Recent Developments
  19. 6.4 Smith Medical
  20. 6.4.1 Smith Medical Company Information
  21. 6.4.2 Smith Medical Business Overview
  22. 6.4.3 Smith Medical Biologic Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Smith Medical Biologic Therapeutic Drug Product Portfolio
  24. 6.4.5 Smith Medical Recent Developments
  25. 6.5 Retractable Technologies, Inc.
  26. 6.5.1 Retractable Technologies, Inc. Company Information
  27. 6.5.2 Retractable Technologies, Inc. Business Overview
  28. 6.5.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Retractable Technologies, Inc. Biologic Therapeutic Drug Product Portfolio
  30. 6.5.5 Retractable Technologies, Inc. Recent Developments
  31. 6.6 Novartis Global
  32. 6.6.1 Novartis Global Company Information
  33. 6.6.2 Novartis Global Business Overview
  34. 6.6.3 Novartis Global Biologic Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Global Biologic Therapeutic Drug Product Portfolio
  36. 6.6.5 Novartis Global Recent Developments
  37. 6.7 H. Lundbeck A/S
  38. 6.7.1 H. Lundbeck A/S Company Information
  39. 6.7.2 H. Lundbeck A/S Business Overview
  40. 6.7.3 H. Lundbeck A/S Biologic Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 H. Lundbeck A/S Biologic Therapeutic Drug Product Portfolio
  42. 6.7.5 H. Lundbeck A/S Recent Developments
  43. 6.8 GlaxoSmithKline Plc.
  44. 6.8.1 GlaxoSmithKline Plc. Company Information
  45. 6.8.2 GlaxoSmithKline Plc. Business Overview
  46. 6.8.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 GlaxoSmithKline Plc. Biologic Therapeutic Drug Product Portfolio
  48. 6.8.5 GlaxoSmithKline Plc. Recent Developments
  49. 6.9 Concord Biotech
  50. 6.9.1 Concord Biotech Company Information
  51. 6.9.2 Concord Biotech Business Overview
  52. 6.9.3 Concord Biotech Biologic Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Concord Biotech Biologic Therapeutic Drug Product Portfolio
  54. 6.9.5 Concord Biotech Recent Developments
  55. 6.10 Aurobindo Pharma Ltd.
  56. 6.10.1 Aurobindo Pharma Ltd. Company Information
  57. 6.10.2 Aurobindo Pharma Ltd. Business Overview
  58. 6.10.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product Portfolio
  60. 6.10.5 Aurobindo Pharma Ltd. Recent Developments
7 North America
  1. 7.1 North America Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Biologic Therapeutic Drug Market Size by Country (2021-2026)
  3. 7.3 North America Biologic Therapeutic Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Biologic Therapeutic Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Biologic Therapeutic Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Biologic Therapeutic Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Biologic Therapeutic Drug Market Size by Country (2021-2026)
  3. 10.3 South America Biologic Therapeutic Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Biologic Therapeutic Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst